New eye drops aim to heal corneal damage and restore sensation
NCT ID NCT06975748
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental eye drop called STSP-0902 for people with neurotrophic keratitis, a rare condition where the cornea loses sensation and can develop ulcers. The trial will enroll 48 adults with moderate to severe disease. Participants will receive either the active eye drop or a placebo, applied 3 or 6 times daily for 8 weeks. The main goals are to check safety and see if the drops help heal the cornea and improve eye sensation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- STSP-0902 ophthalmic solution (eye drops)
- What this could lead to
- If it works, this could provide a new treatment option to heal corneal damage and restore sensation in people with neurotrophic keratitis.
- What could go wrong
- This is an early Phase 2 trial with only 48 participants, so results may not apply to everyone. The treatment may not work better than placebo, and eye drops can cause irritation or other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROTROPHIC KERATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shandong First Medical University Affiliated Eye Hospital
RECRUITINGJinan, Shandong, 250021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye drops show promise for healing corneal damage
- New eye drops aim to heal damaged corneas
- New eye drop shows promise for rare corneal disease
- Gene therapy eye drops aim to heal corneas in rare nerve disorder
- Could a simple ingredient boost dry eye drops?
- New eye test could unlock secrets of ocular pain